BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 25874052)

  • 1. Serum 25(OH) Vitamin D levels is not associated with disability in multiple sclerosis patients: A case-control study.
    Nikanfar M; Taheri-Aghdam AA; Yazdani M; Shaafi S; Masoudian N; Akbari H; Youhanaee P; Abbaszadeh H
    Iran J Neurol; 2015 Jan; 14(1):17-21. PubMed ID: 25874052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of seasonal serum 25-hydroxyvitamin D levels with disability and relapses in relapsing-remitting multiple sclerosis.
    Brola W; Sobolewski P; Szczuchniak W; Góral A; Fudala M; Przybylski W; Opara J
    Eur J Clin Nutr; 2016 Sep; 70(9):995-9. PubMed ID: 27026420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is serum vitamin D levels associated with disability in patients with newly diagnosed multiple sclerosis?
    Hatamian H; Bidabadi E; Seyed Saadat SM; Saadat NS; Kazemnezhad E; Ramezani H; Bakhshayesh B
    Iran J Neurol; 2013; 12(2):41-6. PubMed ID: 24250900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D and disability in relapsing-remitting multiple sclerosis in patients with a Mexican background.
    Rito Y; Flores J; Fernández-Aguilar A; Escalante-Membrillo C; Barboza MA; Amezcua L; Corona T
    Acta Neurol Belg; 2018 Mar; 118(1):47-52. PubMed ID: 28975580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D and body mass index in Egyptian multiple sclerosis patients.
    Zamzam D; Foad M; Swelam M; AbdelHafez M; AbdelNasser A; Mahmoud R; Aref H; Zakaria M
    Mult Scler Relat Disord; 2019 Feb; 28():313-316. PubMed ID: 30823981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D is associated with degree of disability in patients with fully ambulatory relapsing-remitting multiple sclerosis.
    Thouvenot E; Orsini M; Daures JP; Camu W
    Eur J Neurol; 2015 Mar; 22(3):564-9. PubMed ID: 25530281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of serum 25-hydroxyvitamin D levels with multiple sclerosis severity and progression in a case-control study from China.
    Zhang Y; Liu G; Han X; Dong H; Geng J
    J Neuroimmunol; 2016 Aug; 297():127-31. PubMed ID: 27397085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum 25-hydroxyvitamin D levels in multiple sclerosis patients from the north of Portugal.
    Bettencourt A; Boleixa D; Reguengo H; Samões R; Santos E; Oliveira JC; Silva B; Costa PP; da Silva AM
    J Steroid Biochem Mol Biol; 2018 Jun; 180():137-141. PubMed ID: 28951256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin d3 concentration correlates with the severity of multiple sclerosis.
    Shahbeigi S; Pakdaman H; Fereshtehnejad SM; Nikravesh E; Mirabi N; Jalilzadeh G
    Int J Prev Med; 2013 May; 4(5):585-91. PubMed ID: 23930170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of serum 25(OH) vitamin D3 concentration with severity of multiple sclerosis.
    Harandi AA; Shahbeigi S; Pakdaman H; Fereshtehnejad SM; Nikravesh E; Jalilzadeh R
    Iran J Neurol; 2012; 11(2):54-8. PubMed ID: 24250862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low vitamin D-25(OH) level in Indonesian multiple sclerosis and neuromyelitis optic patients.
    Kusumadewi W; Imran D; Witjaksono F; Pakasi TA; Rusmana AI; Pangeran D; Marwadhani SS; Maharani K; Estiasari R
    Mult Scler Relat Disord; 2018 Oct; 25():329-333. PubMed ID: 30195201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D deficiency is associated with disability and disease progression in multiple sclerosis patients independently of oxidative and nitrosative stress.
    Oliveira SR; Simão ANC; Alfieri DF; Flauzino T; Kallaur AP; Mezzaroba L; Lozovoy MAB; Sabino BS; Ferreira KPZ; Pereira WLCJ; Kaimen-Maciel DR; Dichi I; Reiche EMV
    J Neurol Sci; 2017 Oct; 381():213-219. PubMed ID: 28991684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of vitamin D status with multiple sclerosis in a case-control study from Morocco.
    Skalli A; Ait Ben Haddou EH; El Jaoudi R; Razine R; Mpandzou GA; Tibar H; El Fahime E; Bouslam N; Alami A; Benomar A; Hajjout K; Yahyaoui M; Bouhouche A
    Rev Neurol (Paris); 2018 Mar; 174(3):150-156. PubMed ID: 29525037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D Status Does Not Affect Disability Progression of Patients with Multiple Sclerosis over Three Year Follow-Up.
    Muris AH; Smolders J; Rolf L; Klinkenberg LJ; van der Linden N; Meex S; Damoiseaux J; Hupperts R
    PLoS One; 2016; 11(6):e0156122. PubMed ID: 27276080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low vitamin D, but not tobacco use or high BMI, is associated with long-term disability progression in multiple sclerosis.
    Wesnes K; Myhr KM; Riise T; Kvistad SS; Torkildsen Ø; Wergeland S; Holmøy T; Midgard R; Bru A; Edland A; Eikeland R; Gosal S; Harbo HF; Kleveland G; Sørenes YS; Øksendal N; Bjørnevik K
    Mult Scler Relat Disord; 2021 May; 50():102801. PubMed ID: 33636616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-22 Level in Patients with Multiple Sclerosis and Its Relationship with Vitamin D and Vitamin D Receptor Levels.
    Khedr AMB; Shaker OG; Hassan A; Hussein M; Kamal YS; Azouz TA
    Neuroimmunomodulation; 2022; 29(2):128-134. PubMed ID: 34537762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia.
    van der Mei IA; Ponsonby AL; Dwyer T; Blizzard L; Taylor BV; Kilpatrick T; Butzkueven H; McMichael AJ
    J Neurol; 2007 May; 254(5):581-90. PubMed ID: 17426912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b.
    Fitzgerald KC; Munger KL; Köchert K; Arnason BG; Comi G; Cook S; Goodin DS; Filippi M; Hartung HP; Jeffery DR; O'Connor P; Suarez G; Sandbrink R; Kappos L; Pohl C; Ascherio A
    JAMA Neurol; 2015 Dec; 72(12):1458-65. PubMed ID: 26458124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D deficiency and reduced bone mineral density in multiple sclerosis: effect of ambulatory status and functional capacity.
    Ozgocmen S; Bulut S; Ilhan N; Gulkesen A; Ardicoglu O; Ozkan Y
    J Bone Miner Metab; 2005; 23(4):309-13. PubMed ID: 15981027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis.
    Soilu-Hänninen M; Laaksonen M; Laitinen I; Erälinna JP; Lilius EM; Mononen I
    J Neurol Neurosurg Psychiatry; 2008 Feb; 79(2):152-7. PubMed ID: 17578859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.